The effect of aortic morphology on peri-operative mortality of ruptured abdominal aortic aneurysm by IMPROVE Trail Investigators
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Aims To investigatewhether aneurysm shape and extent, which indicatewhether a patient with ruptured abdominal aortic an-
eurysm (rAAA) is eligible for endovascular repair (EVAR), influence the outcome of both EVAR and open surgical repair.
Methods
and results
The influence of six morphological parameters (maximum aortic diameter, aneurysm neck diameter, length and conical-
ity, proximal neck angle, andmaximumcommon iliac diameter)onmortality and reinterventionswithin30dayswas inves-
tigated in rAAApatients randomized beforemorphological assessment in the ImmediateManagement of the Patientwith
Rupture: Open Versus Endovascular strategies (IMPROVE) trial. Patients with a proven diagnosis of rAAA, who under-
went repair and had their admission computerized tomography scan submitted to the core laboratory, were included.
Among 458 patients (364 men, mean age 76 years), who had either EVAR (n ¼ 177) or open repair (n ¼ 281) started,
there were 155 deaths and 88 re-interventions within 30 days of randomization analysed according to a pre-specified
plan. Themeanmaximum aortic diameter was 8.6 cm. There were no substantial correlations between the six morpho-
logical variables. Aneurysm neck length was shorter in those undergoing open repair (vs. EVAR). Aneurysm neck length
(mean 23.3, SD 16.1 mm) was inversely associated with mortality for open repair and overall: adjusted OR 0.72 (95% CI
0.57, 0.92) for each 16 mm (SD) increase in length. There were no convincing associations of morphological parameters
with reinterventions.
Conclusion Short aneurysmnecks adversely influencemortality afteropen repairof rAAAandpreclude conventional EVAR.Thismay
help explain why observational studies, but not randomized trials, have shown an early survival benefit for EVAR.
Clinical trial
registration:
ISRCTN 48334791.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Keywords Aneurysm † Aorta † Imaging † Rupture † Surgery † Stent grafts
Introduction
Three recent randomized trials have shown that both endovascular
and open repair of ruptured abdominal aortic aneurysms (rAAAs)
can be performed with similar operative mortality,1–3 and this has
been confirmed in a systematic review with meta-analysis.4 In con-
trast, systematic reviews of observational studies have shown a
much lower operative mortality after endovascular repair vs. open
repair.5,6 If large enough, randomized trials can investigate whether
specific sub-groups of patients (by age, gender, and fitness) may
derive particular benefit from either endovascular or open repair.
However, aortic morphology, likely to be a key factor controlling
the success of endovascular aneurysm repair (EVAR) for ruptured
aneurysms, has not been investigated in detail previously. Aortic
morphology also might be an important factor in open repair as
suggested by a retrospective review of .200 cases of open repair
for aneurysm rupture in a single Swiss centre.7
Nearly, all patients with rAAA undergo computerized tomog-
raphy (CT) scan, so that aortic morphology can be assessed
rapidly. One liberal definition of suitability for endovascular
repair, which has been used by laboratories for centralized assess-
ment ofCT scans, includes an aneurysmneck length ≥ 10 mm, neck
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diameter ,32 mm, and neck angle ,608.8 The Swiss study indi-
cated that the 30-day mortality for open repair of patients outside
this definition was increased by 8- to 9-fold compared with those
within this definition,7 whereas a Dutch study found no difference.9
There are no previous reports of whether any specific morpho-
logical features (including maximum aneurysm diameter) influence
the success of either EVAR or open repair and should be used to
guide the type of emergency repair selected for individual patients.
Here, this issue of how aortic morphology influences outcome
of ruptured aneurysm repair, after either EVAR or open repair, is
addressed using data from the IMPROVE trial.2 This also extends to
exploring whether aortic morphology contributed to the surprising
early finding of the IMPROVE trial that women appeared to benefit
more from an endovascular strategy than men.2 This was an import-
ant observation, since in general the mortality of women undergoing
repair of a ruptured aneurysm is higher than in men.10,11
Methods
In the IMPROVE trial,2 613 eligible patients, with an in-hospital clinical
diagnosis of rupturedAAA,were randomized before anatomical suitabil-
ity for EVAR had been ascertained, either to a strategy of EVAR if consid-
ered anatomically feasible oropen repair. Patientswhowere randomized
to the endovascular strategy group but following immediate CT scan
were deemed to have an aortic anatomy unsuitable for EVAR were, by
protocol, treated with open repair. The 613 patients derived from a
total cohort of 1275 patients: half (352/672) of the non-randomized
patients were moribund upon admission with repair considered futile,
and died without aneurysm repair. Ethical approval for the participation
in the IMPROVE trial of patients in England and Wales was from South-
Central Berkshire Research Ethics Committee 08/H0505/173, in Scot-
land from Scotland A Research Ethics Committee 08/MRE00/90 and in
Canada from University of Western Ontario Health Sciences Research
Ethics Board 17698. This study included all patients randomized in the
IMPROVE trial,2 with a confirmed diagnosis of ruptured AAA, a pre-
operativeCTscan available for core laboratory analysis andwhoreceived
an operation to repair the rupture. This group consisted of 458 patients
(364 men and 94 women) Figure 1. Groups were analysed according to
operation received and not by randomized group (the open repair
group contains those randomized to EVAR strategy who were found to
be not anatomically suitable); hence, the results presented are observa-
tional and therefore careful control of potential confounding was
required. There are no ESC guidelines for the management of ruptured
AAA.
CT scans
General guidance on the CT scanning protocol to be used was provided
in the IMPROVE Trial protocol, prior to site initiation. The guidance
included suggested volumes of contrast to be used, extent of scan
required, scan thickness, and acquisition delay (www.imperial.ac.uk/
medicine/improvetrial). In a minority of CT scans, no radiographic con-
trast was used (due to patient contrast allergy or the presence of renal
impairment). In these cases, only limited data were recorded from the
CT scans.
Analysis of CT scan data
CT scans performedwithin the trial were analysed at St George’s Vascu-
lar Institute core laboratory using the St George’s Vascular Institute
Protocol12 to provide independent diagnosis of rupture and comprehen-
sively characterize the aneurysm morphology. This protocol is accurate
and reproducible with high levels of inter/intraobserver agreement.12
The CT images were acquired in the DICOM (Digital Image and
Communication in Medicine) format from the hospital archive. The
DICOM files were transferred on anonymized CDs to the core lab and
analysed using CT reconstruction software (3Surgery; 3Mensio Medical
Imaging B.V., Bilthoven, The Netherlands). After semi-automated 3D
segmentation of the aorta, a central luminal line (CLL) was defined and
installed, then multiplanar reformatted images were obtained in parallel
(vessel stretched) and perpendicular (orthogonal) views. A baseline
was then manually identified on the stretched vessel view at the level
of the lowest renal artery to start the measurements. Lengths were
measured along the CLL in the stretched vessel view as the distance
between two predefined anatomical landmarks. Total (external wall
to external wall), luminal, and non-luminal volumes were measured
semi-automatically. The following standard definitions are made:
(i) Aneurysm neck: from the lowest renal artery to the first point of
significant aneurysmal dilatation.
(ii) Access vessels: common iliac artery (CIA) from the aortic bifurcation
to the iliac bifurcation.
A detailed description of the other morphological definitions and
measurements analysed may be found elsewhere.12
Outcomes
The primary outcome is mortality, with a secondary outcome of any
reintervention, both within 30 days of randomization. Following the
review of initial results, 24 h mortality also was assessed.
Statistical analysis
This was conducted according to a pre-specified plan, published on the
trial web site http://www1.imperial.ac.uk/biosurgerysurgicaltechnology/
clinical_trials_outcomes/vasculardisease/clinicaltrials/improvetrial/health
care_professionals/resources/ before the data were inspected and ana-
lysed. As previously,2 missing datawere multiply imputed before analysis
using chained equations (variables used for imputation are listed in Sup-
plementary material online, Table S1). The analyses focused on repairs
performed on aortas within and outside liberal instructions for use,8 as
well six morphological variables: maximum AAA diameter, aneurysm
neck diameter at the distal renal artery, aneurysm neck length, neck
conicality, proximal neck a-angulation, and maximum common iliac
diameter. The proximal neck a-angulation was selected over the distal
b-angulation used in IFU, because of clinician preference (a and b
angles were correlated, r ¼ 0.59). For neck conicality, the ratio of the
most distal neck diameter measured (D1) to the diameter at the distal
Figure 1 Selection of patients for analysis.
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renal artery (D2) relative to the centre line distance between these two
levels (L) was used. The relative change per unit length is then calculated
as (D1/D2-1)/L. Logistic regression models were fitted adjusting for
pre-specified confounders (age, sex, Hardman index,13 lowest recorded
systolic blood pressure, randomized group, and treatment commenced).
A further model additionally adjusted the estimates for the effect of all
the other morphological variables. For the IFU analysis, odds ratios,
95% confidence intervals and P-values (calculated using Wald’s test)
are presented, with an additional sensitivity analysis to allow for the
type of anaesthesia used for patients receiving EVAR.14 Each of the six
morphological variables were considered as continuous covariates
and odds ratios are reported based on a 1 SD increase to allow fair
comparison of their relative importance. The interaction with sex was
investigated in all models. Goodness of fit was assessed using the
Hosmer–Lemeshow test, forming 10 equal-sized groups based on the
predicted probabilities.15 All analyses were conducted using Stata statis-
tical software, version 12 (StataCorp. 2011. Stata Statistical Software:
Release 12. College Station, TX, USA: StataCorp LP).
Results
The selection of the 458 patients for this analysis is shown in Figure 1
and their baseline characteristics, including aneurysm morphology
measurements are shown in Table 1. Patients who commenced
EVAR were on average older (P ¼ 0.0032), more likely to have
aortic anatomy within IFU (P, 0.001), had longer (P, 0.001) and
less conical (P ¼ 0.030) aneurysm necks and had larger common
iliac arteries (P ¼ 0.040). These differences were mainly attributed
to patients who were not anatomically suitable for EVAR receiving
open repair; full reasons for final treatment were reported previous-
ly.2 Ninety-five per cent limits of agreement of inter-observer
variability in morphology measurements were assessed using Bland
Altman plots (based on three independent observers): maximum
aneurysm diameter+4 mm, neck diameter+2 mm, neck length+
4 mm, and common iliac diameter+2 mm. There were no strong
correlations between the sixmorphological variables. The aneurysm
morphologywas described aswithin liberal IFU in 58%patients; there
were 155 deaths and 88 re-interventions within 30 days. As in previ-
ous series,8 the description ofwithin liberal IFU fromcore laboratory
aneurysm neck measurements was not concordant with local hos-
pital definition of suitability for EVAR (Supplementary material
online, Table S2). The distribution of maximum aneurysm diameter
(at a mean systolic pressure of about 95 mmHg) is shown in
Figure 2, displaying a steep increase in the frequency of ruptures for
aneurysm sizes .60 mm.
Mortality
The association between aneurysm morphology and 30-day mortal-
ity is shown in Table 2, adjusting for the pre-specified confounders.
Further adjustments for the other morphological measurements
and a complete-case analysis gave similar results and are shown in
Supplementary material online, Tables S3 and S4. There was no evi-
dence of lack of fit in any of the complete-case analyses. Patients
with aneurysm morphology within liberal IFU appeared to have
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Table 1 Baseline characteristics of the analysis population
N EVAR commenced
(n 5 177)
Open commenced
(n5 281)
P-valuea Total (n5 458)
Age (years) 458 77.4 (7.1) 75.3 (7.5) 0.0032 76.1 (7.5)
Men, n (%) 458 148 (83.6) 216 (76.9) 0.082 364 (79.5)
Hardman Index 405 1.02 (0.87) 0.91 (0.87) 0.15 0.96 (0.87)
Lowest pre-operative SBP, mmHg 429 94.6 (27.4) 94.8 (30.9) 0.93 94.7 (29.6)
Within liberal IFU, n (%) 389 108 (71.5) 119 (50.0) ,0.001 227 (58.4)
Max aneurysm diameter (mm) 427 85.6 (18.2) 86.3 (17.0) 0.59 86.0 (17.4)
Aneurysm neck diameter at distal renal artery (mm) 374 25.1 (3.8) 25.9 (4.7) 0.21 25.6 (4.4)
Neck length (mm) 409 29.2 (14.8) 19.5 (15.8) ,0.001 23.3 (16.1)
Conicality (% change per mm length) 361 0.46 (0.89) 0.93 (1.99) 0.030 0.73 (1.63)
Proximal neck angle (degrees) 406 31.0 (19.0) 33.9 (20.9) 0.17 32.7 (20.2)
Maximum common iliac diameter (mm) 404 21.5 (8.1) 20.6 (9.3) 0.040 21.0 (8.8)
Mean (SD) unless otherwise stated.
aWilcoxon rank-sum test for continuous variables, Pearson x2 test for binary variables.
Figure 2 Distribution of maximum aneurysm diameters (at a
mean systolic pressure of 95 mmHg).
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Table 2 Aortic morphology and 30-day mortality (with multiple imputation for missing variables)
Variable EVAR commenced,
50 deaths, n5 177
Open commenced,
105 deaths, n 5 281
Combineda,
155 deaths, n5 458
Odds ratio
(95% CI)
P-value Odds ratio
(95% CI)
P-value Odds ratio
(95% CI)
P-value
Within liberal IFU ( vs. outside) 0.72 (0.33, 1.61) 0.42 0.61 (0.35,1.06) 0.081 0.64 (0.41, 1.01) 0.054
Maximum AAA diameter (per 17 mm increase) 0.95 (0.66, 1.38) 0.80 0.83 (0.63, 1.10) 0.19 0.89 (0.71, 1.10) 0.27
Aneurysm neck diameter at distal renal artery (per 4 mm
increase)
1.18 (0.76, 1.82) 0.47 0.96 (0.69, 1.33) 0.79 1.03 (0.80, 1.34) 0.81
Aneurysm neck length (per 16 mm increase) 0.83 (0.54, 1.26) 0.38 0.67 (0.49, 0.91) 0.010 0.72 (0.57, 0.92) 0.009
Neck conicality (per 1.6% per mm change increase) 1.19 (0.63, 2.26) 0.60 1.17 (0.80, 1.70) 0.42 1.18 (0.84, 1.66) 0.34
Proximal aneurysm neck (a) angulation (per 208 increase) 0.93 (0.63, 1.37) 0.70 0.85 (0.65, 1.11) 0.22 0.88 (0.71, 1.09) 0.25
Maximum common iliac diameter (per 9 mm increase) 1.38 (0.93, 2.05) 0.11 1.09 (0.84, 1.41) 0.51 1.15 (0.93, 1.42) 0.21
All models adjusted for age, sex, Hardman Index, lowest recorded systolic blood pressure, and randomized group. Odds ratios are presented per standard deviation increase
of morphological parameter.
aAlso adjusted for operation commenced.
Figure 3 Distribution of aneurysm neck lengths in the complete cohort and stratified according to operation started and sex.
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lowermortality for both EVAR and open repair, although overall this
one-third reduction in mortality was only of borderline significance
(P ¼ 0.054). Further adjustment for type of anaesthesia used
(general vs. local) gave a similar estimate for patients who com-
menced EVAR. Neck length, but none of the other morphological
measurements, was associated with mortality: the odds ratio point
estimate was more extreme in patients undergoing open repair
than EVAR. Overall, for a 16 mm (one SD) increase in neck length,
the adjusted odds ratio was 0.72 (95% CI 0.57, 0.92), P ¼ 0.009.
The distribution of neck length was right skewed, with consider-
able numbers of patients having zero neck lengths, or juxtarenal
aneurysms (Figure 3). The mortality results for patients by defined
clinical categories of neck length are shown in Table 3 and Figure 4.
Few patients with neck lengths ,10 mm had EVAR started
(Figure 3) and their mortality was high, but limited numbers could
account for why neck length did not achieve statistical significance
in this group (Table 2). For patients in whom open repair was
started, the 30-day mortality increased steadily with decreasing
neck length. For patientswith neck lengths of≥15 mm, themortality
from EVAR and open repair appeared similar.
The strong inverse association between neck length and 30-day
mortality did not appear to result from other potential confounders.
Therewas no evidence of thosewith shorter necks beingmore likely
to have pre-operative shockor acutemyocardial ischaemia, spending
a longer time in theatre, or requiring post-operative renal replace-
ment therapy (data not shown). Further, a post hoc comparison of
supra-renal aortic diameter (measured 15 mm proximal to the
proximal renal artery) and neck length showed little correlation
between these measurements.
Similarly, 24 h mortality (79 deaths) increased with decreasing
aneurysm neck length: for each 16 mm (one SD) increase in neck
length; adjusted odds ratio 0.66 (95% CI 0.48, 0.90), P ¼ 0.008.
Since outcomes after rupture in women are usually worse than
those in men, we further investigated whether neck length might
be influential. The distribution of several morphological parameters
is different in men and women (Supplementary material online,
Table S5). In particular, aneurysm neck length is different (Wilcoxon
rank-sum test P ¼ 0.010, Figure 3), as is common iliac diameter (mean
17.9 mm in women vs. 21.8 mm in men, with iliac aneurysm being
more common in men). Thirty-day mortality for women and men,
by categories of neck length, is shown in Table 3. A higher proportion
of women than men presented with juxtarenal aneurysms: the pro-
portion of women and men presenting with neck length 0–4 mm
was 24% (20/84) and 12% (40/325), respectively. Women have
similar or higher mortality than men for all neck lengths ,30 mm.
None of the tests of interaction by sex in the main analyses was
statistically significant.
Reinterventions
This analysis included 412 patients after exclusion of those patients
who either did not leave the operating theatre alive (n ¼ 41) or
had missing re-intervention data (n ¼ 5). The need for one or
more re-intervention within 30 days was not strongly associated
with anyof themorphological parameters, although therewere asso-
ciations of borderline statistical significance between bothmaximum
aortic diameter and common iliac diameter and re-intervention
(Table4): data further adjusted for theothermorphologicalmeasure-
ments and complete-case analyses were similar and are shown in
Supplementary material online, Tables S6 and S7.
Discussion
A singlemorphological parameter, aneurysm neck length, appears to
have a significant influence on operative mortality following surgery
for ruptured abdominal aortic aneurysm, independent of known
confounders. As the aneurysm neck shortens, conventional EVAR
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Table 3 Overall 30-day mortality by categories of neck length and stratified by procedure started and sex
Neck length Total
0–4 mm 5–9 mm 10–14 mm 15–29 mm 30 mm1
Overall 50% (30/60) 49% (17/35) 43% (17/40) 29% (40/139) 24% (33/135) 34% (137/409)
EVAR commenced 33% (2/6) 63% (5/8) 20% (2/10) 27% (18/66) 24% (17/71) 27% (44/161)
Open commenced 52% (28/54) 44% (12/27) 50% (15/30) 30% (22/73) 25% (16/64) 38% (93/248)
Women 50% (10/20) 80% (8/10) 67% (6/9) 38% (8/21) 17% (4/24) 43% (36/84)
Men 50% (20/40) 36% (9/25) 35% (11/31) 27% (32/118) 26% (29/111) 31% (101/325)
Figure 4 The influence of aneurysm neck length, by category,
on 30-day mortality. Effect of neck length on the risk of 30-day
mortality (using multiple imputation), after adjustment for age,
sex, Hardman Index, lowest recorded systolic blood pressure,
randomized group, and treatment commenced.
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becomes either impossible or, if attempted, carries a very high
mortality rate. The strong, but previously unconsidered, relationship
between short aneurysm neck length and high mortality after open
repair explains why mortality after open repair remains high: many
of these patients have juxtarenal aneurysms. Open juxtarenal aneur-
ysmrepair requires cross-clampingof the aorta above the renal arter-
ies, with inevitable compromise of the visceral circulation, especially
in shockedpatients. In contrast, for longer aneurysmnecks (15 mm
or more), infra-renal aortic clamps can be used for open repair, with
operative mortality similar to that for EVAR (25%).
Most ruptured aneurysms are very large even in the presence of
hypotension, mean diameter 8.6 cm in this series, compared with
at least 2 cm smaller in most elective repair series16 and a diameter
of 2 cmor less in healthy infra-renal aorta. As the aneurysm increases
in diameter, it might be expected that aneurysmal dilatation would
extend both proximally and distally to involve a greater length of
the aorta and diminish the proportion of patients within liberal IFU
for EVAR (just 58% in this series). Increasing aneurysm diameter
also increases the risk of complications and reinterventions after
elective endovascular repair.17,18 Although the anatomical assess-
ment of suitability for EVAR is defined primarily by neck length, diam-
eter and angle, and access artery characteristics, it was neck length
that was the most common factor precluding EVAR (,10 mm in
23%, ,15 mm in 33%). For each increase of 15 mm in neck length,
30-day mortality decreased by a factor of 20%, with a similar
effect on 24 h mortality. The design of the IMPROVE trial, where
patients were randomized before assessment of anatomical suitabil-
ity for EVAR, enabled the elucidation of this clinically important rela-
tionship between aneurysm neck length and mortality following
aneurysm repair in patients considered eligible for repair. No conclu-
sion can be drawn for the higher risk ormoribund patientswhowere
excluded from the trial.
This finding may help explain why population-level observational
studies and meta-analyses of observational studies report that for
ruptured aneurysm operative mortality for EVAR is about half that
for open repair: the long aneurysm neck patients get EVAR and the
short aneurysm neck patients get open repair. This follows earlier
data from the EVAR-2 trial suggesting that the patients with shorter
neck lengths have a much higher risk of rupture.19 Randomized
trials, which compare patient groups with similar aortic morphology
(particularly neck length) have failed to showany difference in opera-
tive mortality between EVAR and open repair.1–3,20 The association
of short aneurysm neck length with high operative mortality for rup-
tured aneurysm repair also partlymayexplain theworseoutcomes in
women thanmen: aneurysmneck lengthwas shorter inwomen and a
higher proportionofwomen thanmenhave short aneurysmnecksor
juxtarenal aneurysms and open repair is associated with a very high
mortality (Table 3). The women in this series also had common iliac
morphology suitable for the seal of a distal EVAR limb in the
common iliac artery, whereas in men this often might have to
extend into the external iliac artery. Taken together, this might
begin to explain why women, who are morphologically suitable for
EVAR, appear to benefit more than men from an endovascular first
strategy.2
The emerging hypothesis that, for ruptured aneurysms, neck
length is more important than the type of repair, needs to be
tested in a separate large set of unselected patients. No such data
set containing sufficient numbers of both EVAR and open repair
patients could be identified. However, further credence concerning
the key role of neck length comes from this IMPROVE data set by
comparison of 30-daymortality by intention to treat (by randomized
strategy group) and as treated (mimicking an observational study),
with and without adjustment for neck length. The odds ratios for
30-day mortality by intention to treat (unadjusted), as treated
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Table 4 Aortic morphology and the risk of re-intervention within 30 days (with multiple imputation for missing
variables) for 412 patients after exclusion of patients who either did not leave the operating theatre alive (n5 41)
or had missing re-intervention data (n5 5)
Variable EVAR commenced
(23 patients with
re-interventions,
n 5 167)
Open commenced
(65 patients with
re-interventions,
n5 245)
Combineda
(88 patients with
re-interventions,
n 5 412)
Odds ratio
(95% CI)
P-value Odds ratio
(95% CI)
P-value Odds ratio
(95% CI)
P-value
Within IFU ( vs. outside) 0.64 (0.24, 1.67) 0.36 0.95 (0.50, 1.81) 0.87 0.85 (0.50, 1.44) 0.55
Maximum AAA diameter (per 17 mm increase) 0.76 (0.45, 1.29) 0.31 0.80 (0.58, 1.11) 0.18 0.79 (0.60, 1.04) 0.094
Aneurysm neck diameter at distal renal artery
(per 4 mm increase)
1.12 (0.65, 1.92) 0.69 1.20 (0.82, 1.77) 0.35 1.16 (0.85, 1.58) 0.34
Aneurysm neck length (per 16 mm increase) 0.89 (0.53, 1.51) 0.67 1.13 (0.80, 1.61) 0.48 1.06 (0.79, 1.41) 0.72
Neck conicality (per 1.6% per mm change increase) 1.01 (0.41, 2.50) 0.98 0.62 (0.38, 1.01) 0.057 0.70 (0.45, 1.10) 0.12
Proximal aneurysm neck (a) angulation (per 208
increase)
0.78 (0.45, 1.34) 0.37 1.14 (0.86, 1.52) 0.37 1.04 (0.81, 1.35) 0.75
Maximum common iliac diameter (per 9 mm increase) 1.47 (0.94, 2.30) 0.089 1.16 (0.88, 1.54) 0.28 1.24 (0.98, 1.57) 0.071
All models adjusted for age, sex, Hardman Index, lowest recorded systolic blood pressure, and randomized group. Odds ratios are presented per standard deviation increase of
morphological parameter.
aAlso adjusted for operation commenced.
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(unadjusted), and as treated (adjusted for neck length) were 0.87
(0.58, 1.32) P ¼ 0.525, 0.63 (0.41, 0.97) P ¼ 0.034, and 0.78 (0.50,
1.24) P ¼ 0.298, respectively. The unadjusted as-treated estimate,
whichmay be biased due to patient selection, shows a 30-daymortal-
ity benefit for EVAR, but after adjustment for aneurysm neck length
there is no evidence of a difference between 30-day mortality after
EVAR and open repair.
Findings from our analysis of how aneurysm morphology influ-
enced early reintervention rates were less convincing, probably
because patient and events numbers were fewer, not all reinterven-
tions were aneurysm specific and endoleaks are uncommon within
the first 30 days.1 Maximum aortic diameter and common iliac diam-
etermay emerge as important morphological parameters in analyses
of longer term aneurysm-specific reinterventions. This would be
consistent with the relevance of these two parameters in predicting
complications after elective aneurysm repair.17,18
In this era of endovascular therapy, these findings have important
implications for reducing the operative mortality from ruptured
aneurysm repair. First, these patients need to be treated in centres
offering excellence in both endovascular and open repair. Second,
future reporting of the outcome of ruptured aneurysm repair
needs to be by category of neck length, for juxtarenal vs. localized
infra-renal disease, with thoracoabdominal aneurysms reported
separately. Third, endovascular techniques to repair short necked
and juxtarenal aneurysms, including fenestrated or branched endo-
grafts, chimneys or snorkels as adjuncts to conventional EVAR
and endovascular sealing technology, need to be developed and
audited, to identify whether such innovations could lower operative
mortality for this group of patients. Fourth, with aneurysm screening
focusing largely onmen, the proportionofwomen undergoing repair
of ruptured aneurysm may increase and endografts designed for
women, to increase the proportion eligible for endovascular repair,
may be necessary to save lives.
In summary, aneurysm neck length rather than type of repair
(endovascular or open) predicts the early survival from ruptured
abdominal aortic aneurysm repair.
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